SL Science Holding Limited (SLBT) Shares Preclinical Data Showing Activity vs MGMT+ GBM

SL Science reported preclinical data showing its unmodified γδ T cells target MGMT-positive, chemotherapy-resistant glioblastoma cells, presented as poster P-2017 at the Japanese Cancer Association meeting.Material DetailsContext by AI AnalystThis is an early-stage R&D update building on recent pre…